+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Idarubicin Hydrochloride for Injection Market - Global Forecast to 2030- Product Image
Idarubicin Hydrochloride for Injection Market - Global Forecast to 2030- Product Image
Sale

Idarubicin Hydrochloride for Injection Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6123506
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Idarubicin Hydrochloride for Injection plays a critical role in advancing treatment protocols for hematologic malignancies, catalyzing significant shifts in leukemia management worldwide. As the industry responds to evolving clinical, regulatory, and supply chain complexities, manufacturers and healthcare providers are re-evaluating strategies to remain competitive and resilient in a dynamic market landscape.

Market Snapshot: Idarubicin Hydrochloride for Injection Market Overview

The market for Idarubicin Hydrochloride for Injection is shaped by growing demand for effective antineoplastic agents targeting acute myeloid leukemia and acute lymphoblastic leukemia. Its dual action—disrupting DNA and inhibiting topoisomerase II—positions it as a core therapy within induction and consolidation regimens. Strategic use of this injection in both adult and pediatric settings illustrates its flexibility. Recent advancements have improved administration methods, particularly for outpatient infusions, and clinical adoption reflects ongoing integration with targeted agents and evolving supportive care.

Scope & Segmentation

This analysis delivers comprehensive segmentation and coverage of the Idarubicin Hydrochloride for Injection market, focusing on regional trends, end users, formulations, and competitive positioning to guide stakeholders in strategic decision making. The following critical categories are addressed:

  • Indication: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
  • End User: Clinics, Hospitals, Community Hospitals, Tertiary Care Hospitals, Specialty Oncology Centers
  • Patient Type: Adult, Pediatric
  • Packaging Type: Multi Dose Vial, Single Dose Vial
  • Dosage Strength: 10 mg, 5 mg
  • Manufacturer Type: Generic, Innovator
  • Application: Consolidation Therapy, Induction Therapy
  • Administration Setting: Inpatient, Outpatient
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (selected markets such as United Kingdom, Germany, France, Spain, United Arab Emirates, South Africa), and Asia-Pacific (including China, India, Japan, Australia, and others)
  • Key Industry Players: Sandoz AG, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Fresenius Kabi AG, Viatris Inc., Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Apotex Inc., Cipla Limited

Key Takeaways

  • Idarubicin Hydrochloride for Injection enables precision dosing and high bioavailability, making it essential in modern oncology protocols.
  • Protocols increasingly integrate digital health solutions, allowing for more adaptive dosing and improved monitoring of adverse events, such as cytopenia and cardiotoxicity.
  • Combination regimens with immunotherapies and targeted agents are prompting updates to treatment guidelines and driving clinical trials in both adult and pediatric populations.
  • Innovations in delivery, including liposomal encapsulation and on-demand infusion, facilitate outpatient therapy and minimize hospital stays.
  • Collaborative agreements between contract manufacturing organizations and leading pharmaceutical firms address capacity fluctuations and promote supply chain agility.
  • Distinct segmentation by indication, patient type, and administration setting underscores the need for tailored strategies in procurement, formulation, and inventory management.

Tariff Impact and Supply Chain Considerations

The introduction of United States tariffs in 2025 on key raw materials and excipients for Idarubicin Hydrochloride for Injection is prompting manufacturers to diversify sourcing and pursue nearshoring to reduce cross-border risks. Increased supply chain complexity has accelerated adoption of advanced quality controls and process optimizations. Hospitals and pharmaceutical companies are renegotiating supplier agreements to maintain stability and manage costs. Regulatory agencies are responding by streamlining pathways for domestic production, helping ensure continuity despite shifting trade landscapes.

Methodology & Data Sources

Primary data is sourced from expert interviews with hematology-oncology clinicians, pharmacists, and procurement teams, while secondary data incorporates regulatory filings, peer-reviewed publications, and company disclosures. Triangulation of qualitative insights with quantitative indicators ensures validity and depth. Expert panels and cross-verification protocols guarantee accurate and actionable findings.

Why This Report Matters

  • Provides actionable intelligence on market movements, enabling manufacturers and investors to anticipate demand shifts and competitive pressures.
  • Supports evidence-based decision-making for healthcare providers exploring novel regimen combinations and emergent delivery strategies.
  • Guides procurement and supply chain leaders in navigating regulatory changes and optimizing sourcing under new tariff conditions.

Conclusion

Idarubicin Hydrochloride for Injection remains central to evolving leukemia therapies, with its value amplified by technological innovation and supply chain adaptation. This report delivers focused, strategic insights for leaders tasked with driving success amidst changing clinical and economic realities.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of liposomal drug delivery formulations to reduce cardiotoxicity and improve idarubicin tolerability
5.2. Increasing approvals of generic idarubicin hydrochloride products driving price competition in key markets
5.3. Integration of pharmacogenomic testing into idarubicin dosing to optimize treatment efficacy and safety
5.4. Expanding partnerships between biopharma and CDMOs for large scale manufacture of injectable idarubicin formulations
5.5. Rising off-label investigational use of idarubicin in combination therapies targeting solid tumors in clinical trials
5.6. Stringent regulatory scrutiny over impurity profiles and manufacturing processes impacting supply continuity
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Idarubicin Hydrochloride for Injection Market, by Indication
8.1. Introduction
8.2. Acute Lymphoblastic Leukemia
8.3. Acute Myeloid Leukemia
9. Idarubicin Hydrochloride for Injection Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Hospitals
9.3.1. Community Hospital
9.3.2. Tertiary Care Hospital
9.4. Specialty Oncology Centers
10. Idarubicin Hydrochloride for Injection Market, by Patient Type
10.1. Introduction
10.2. Adult
10.3. Pediatric
11. Idarubicin Hydrochloride for Injection Market, by Packaging Type
11.1. Introduction
11.2. Multi Dose Vial
11.3. Single Dose Vial
12. Idarubicin Hydrochloride for Injection Market, by Dosage Strength
12.1. Introduction
12.2. 10 mg
12.3. 5 mg
13. Idarubicin Hydrochloride for Injection Market, by Manufacturer Type
13.1. Introduction
13.2. Generic
13.3. Innovator
14. Idarubicin Hydrochloride for Injection Market, by Application
14.1. Introduction
14.2. Consolidation Therapy
14.3. Induction Therapy
15. Idarubicin Hydrochloride for Injection Market, by Administration Setting
15.1. Introduction
15.2. Inpatient
15.3. Outpatient
16. Americas Idarubicin Hydrochloride for Injection Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Idarubicin Hydrochloride for Injection Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Idarubicin Hydrochloride for Injection Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Sandoz AG
19.3.2. Teva Pharmaceutical Industries Ltd.
19.3.3. Pfizer Inc.
19.3.4. Fresenius Kabi AG
19.3.5. Viatris Inc.
19.3.6. Dr. Reddy's Laboratories Ltd.
19.3.7. Sun Pharmaceutical Industries Ltd.
19.3.8. Hikma Pharmaceuticals PLC
19.3.9. Apotex Inc.
19.3.10. Cipla Limited
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2024 VS 2030 (%)
FIGURE 20. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 31. IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET: RESEARCHAI
FIGURE 32. IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET: RESEARCHSTATISTICS
FIGURE 33. IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET: RESEARCHCONTACTS
FIGURE 34. IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ACUTE LYMPHOBLASTIC LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ACUTE LYMPHOBLASTIC LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ACUTE MYELOID LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COMMUNITY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COMMUNITY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY TERTIARY CARE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY TERTIARY CARE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY SPECIALTY ONCOLOGY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY SPECIALTY ONCOLOGY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MULTI DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MULTI DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY 10 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY 10 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY 5 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY 5 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INNOVATOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INNOVATOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONSOLIDATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONSOLIDATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDUCTION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDUCTION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 105. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 110. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 111. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 114. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 115. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 116. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 117. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 118. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 119. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 122. CANADA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 123. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 124. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 125. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 129. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 130. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 131. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 134. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 135. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 140. MEXICO IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 215. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 220. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 221. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 222. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 223. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 224. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 225. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 226. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 227. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 228. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 229. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 232. GERMANY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 233. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 234. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 235. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 238. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 239. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 240. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 241. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 242. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 243. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 244. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 245. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 246. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 247. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 250. FRANCE IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 269. ITALY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 270. ITALY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 271. ITALY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. ITALY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. ITALY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 274. ITALY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 275. ITALY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 276. ITALY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 277. ITALY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 278. ITALY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 279. ITALY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 280. ITALY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 281. ITALY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2018-2024 (USD MILLION)
TABLE 282. ITALY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY MANUFACTURER TYPE, 2025-2030 (USD MILLION)
TABLE 283. ITALY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. ITALY IDARUBICIN HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-20

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Idarubicin Hydrochloride for Injection market report include:
  • Sandoz AG
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Fresenius Kabi AG
  • Viatris Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Hikma Pharmaceuticals PLC
  • Apotex Inc.
  • Cipla Limited

Related Topics

Related Reports

Isoprenaline Hydrochloride Injection Market - Global Forecast 2025-2030 - Product Image

Isoprenaline Hydrochloride Injection Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Esketamine Hydrochloride Injection Market - Global Forecast 2025-2030 - Product Image

Esketamine Hydrochloride Injection Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Liposome Injection Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Liposome Injection Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Injection Pen Market Size, Share & Trends Analysis Report By Product (Disposable, Reusable), By Application (Osteoporosis, Diabetes, Anaphylaxis), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Injection Pen Market Size, Share & Trends Analysis Report By Product (Disposable, Reusable), By Application (Osteoporosis, Diabetes, Anaphylaxis), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 170 Pages
  • Global
From
Self-injection Devices Market Size, Share & Trends Analysis By Product (Auto Injectors, Pen Injectors), By Usability (Disposable, Reusable), By Application (Cancer, Autoimmune Disorders, Hormonal Disorders), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Self-injection Devices Market Size, Share & Trends Analysis By Product (Auto Injectors, Pen Injectors), By Usability (Disposable, Reusable), By Application (Cancer, Autoimmune Disorders, Hormonal Disorders), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.